| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |